Cargando…

How Should Pathology Findings Influence Treatment in IgA Nephropathy?

Detalles Bibliográficos
Autores principales:	Troyanov, Stéphan, Hladunewich, Michelle A., Reich, Heather N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720810/ https://www.ncbi.nlm.nih.gov/pubmed/35005306 http://dx.doi.org/10.1016/j.ekir.2021.11.001

Ejemplares similares

Renal vascular lesions in IgA nephropathy
por: Baradaran, Azar
Publicado: (2013)

Globally sclerotic glomeruli in IgA nephropathy patients
por: Mohammadi Torbati, Peyman
Publicado: (2012)

The Molecular Phenotype of Endocapillary Proliferation: Novel Therapeutic Targets for IgA Nephropathy
por: Hodgin, Jeffrey B., et al.
Publicado: (2014)

Toward a Clearer Picture of IgA Nephropathy in Spondyloarthritis
por: Canetta, Pietro
Publicado: (2020)

C4d in IgA nephropathy: a marker sans boundaries
por: Mubarak, Muhammed
Publicado: (2016)

Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study
por: Selewski, David T., et al.
Publicado: (2018)

How to optimize the design and implementation of risk prediction tools: focus group with patients with IgA nephropathy
por: Gagliardi, Anna R., et al.
Publicado: (2020)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Current treatment of IgA nephropathy
por: Floege, Jürgen, et al.
Publicado: (2021)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Pathological Role of Tonsillar B Cells in IgA Nephropathy
por: Suzuki, Yusuke, et al.
Publicado: (2011)

The clinical and pathological characteristics of IgA nephropathy patients in Tibet
por: Si, Fenglei, et al.
Publicado: (2022)

Clinical and pathological characteristics in elderly patients with IgA nephropathy
por: Zhang, Yongji, et al.
Publicado: (2023)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Diagnosis and treatment of IgA nephropathy and IgA vasculitis nephritis in Chinese children
por: Zhong, Xuhui, et al.
Publicado: (2022)

Additional Refinement of CKD Prognostication Using Lymphatic Vessel Density: IgA Nephropathy as the Role Model?
por: Kronbichler, Andreas, et al.
Publicado: (2022)

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
por: Coppo, Rosanna, et al.
Publicado: (2014)

Emerging Modes of Treatment of IgA Nephropathy
por: Maixnerova, Dita, et al.
Publicado: (2020)

Role of telitacicept in the treatment of IgA nephropathy
por: Wu, Lijun, et al.
Publicado: (2023)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Pathologic tonsillar findings similar to IgA nephropathy and the role of tonsillectomy in a patient with nephrotic syndrome
por: Enya, Takuji, et al.
Publicado: (2019)

Focal Segmental Glomerulosclerosis: Assessing the Risk of Relapse
por: Troyanov, Stéphan, et al.
Publicado: (2023)

Pathological Scenario with the Mannose-Binding Lectin in Patients with IgA Nephropathy
por: Ohsawa, Isao, et al.
Publicado: (2012)

International Physicians Delphi Survey: Managing Patients With IgA Nephropathy
por: Floege, Jürgen, et al.
Publicado: (2022)

Clinicopathologic Significance of Predominant Lambda Light Chain Deposition in IgA Nephropathy
por: Ravipati, Prasanth, et al.
Publicado: (2022)

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
por: Lee, Mingfeng, et al.
Publicado: (2020)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Coincidental finding of Fabry’s disease in a patient with IgA nephropathy
por: Kakita, Tomoko, et al.
Publicado: (2010)

Extracapillary proliferation in IgA nephropathy; recent findings and new ideas
por: Nasri, Hamid, et al.
Publicado: (2015)

Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
por: Berthelot, Laureline, et al.
Publicado: (2012)

Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome
por: Konieczny, Andrzej, et al.
Publicado: (2021)

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy
por: Sarcina, Cristina, et al.
Publicado: (2016)

Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy
por: Lafayette, Richard A., et al.
Publicado: (2020)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6e4alfj2gtdl2t6747v4ac7vub